Energy & environment · 07/08/2003Updated: 10/17/2026 · 1 min read
Bristol-Meyers Squibb Pharma Company Seeks Approval for License Amendment of Materials License No. 07-00445-40
Summary
The company has submitted a proposal to the relevant authorities for a license amendment, following a finding that the proposed changes do not have a significant impact on the environment, and has made an environmental assessment available for public review.
Original source language: Federal Register — Nuclear Regulatory CommissionOpen original release →